CSF1 and glioblastoma: Although pharmaco-active compounds have demonstrated excellent efficacy in preclinical animal studies against a GEMM of PN GBM, they were not successful in eliminating or decreasing TAM numbers in GBM, suggesting that TAMs gain CSF-1 independence (59).